Literature DB >> 23315923

Dual effect of advanced glycation end products in pancreatic islet apoptosis.

Flavia Costal1, Erika Oliveira, Alexandre Raposo, Adriana Machado-Lima, Elisa Peixoto, Letícia Roma, Laila Santos, José B Lopes Faria, Angelo Rafael Carpinelli, Daniel Giannella-Neto, Marisa Passarelli, Maria Lucia Correa-Giannella.   

Abstract

BACKGROUND: Loss of β-cell function hastens deterioration of metabolic control in type 2 diabetes patients. Besides amyloid deposit and glucolipotoxicity, advanced glycation end products (AGEs) acting through their receptors (RAGE) seem to contribute to this process by promoting islet apoptosis. In order to investigate the role of AGEs in β-cell deterioration, we evaluated the temporal and dose effects of AGE compounds on apoptosis rate, reactive oxygen species generation and expression of pro-apoptotic and anti-apoptotic genes in cultured islets.
METHODS: Rat pancreatic islets were exposed or not for 24, 48, 72 and 96 h to albumin modified by glycoaldehyde. Apoptosis, reactive oxygen species and superoxide content and NADPH oxidase activity were evaluated as well as RNA expression of the genes Ager (codes for RAGE), Bax, Bcl2 and Nfkb1.
RESULTS: In 24 and 48 h, glycoaldehyde elicited a decrease in apoptosis rate in comparison with the control condition concomitantly with a reduction in Bax/Bcl2 RNA ratio and in Nfkb1 RNA expression. In contrast, after 72 and 96 h, glycoaldehyde promoted an increase in apoptosis rate concomitantly with an increase in Bax/Bcl2 RNA ratio and in Nfkb1 RNA expression. In 24 h, glycoaldehyde elicited a decrease in the islet content of reactive oxygen species, whereas after 48 and 72 h, it promoted an opposite effect, increasing superoxide generation. The NADPH oxidase inhibitor VAS2870 attenuated superoxide production, implicating NADPH oxidase as an important source of reactive oxygen species in islets exposed to AGEs.
CONCLUSIONS: Albumin modified by glycoaldehyde exerted a dual effect in cultured pancreatic islets, being protective against apoptosis after short exposure but pro-apoptotic after prolonged exposure.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23315923     DOI: 10.1002/dmrr.2390

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  5 in total

Review 1.  The receptor for advanced glycation endproducts is a mediator of toxicity by IAPP and other proteotoxic aggregates: Establishing and exploiting common ground for novel amyloidosis therapies.

Authors:  Andisheh Abedini; Julia Derk; Ann Marie Schmidt
Journal:  Protein Sci       Date:  2018-07       Impact factor: 6.725

2.  RAGE binds preamyloid IAPP intermediates and mediates pancreatic β cell proteotoxicity.

Authors:  Andisheh Abedini; Ping Cao; Annette Plesner; Jinghua Zhang; Meilun He; Julia Derk; Sachi A Patil; Rosa Rosario; Jacqueline Lonier; Fei Song; Hyunwook Koh; Huilin Li; Daniel P Raleigh; Ann Marie Schmidt
Journal:  J Clin Invest       Date:  2018-01-16       Impact factor: 14.808

3.  Sesamin Ameliorates Advanced Glycation End Products-Induced Pancreatic β-Cell Dysfunction and Apoptosis.

Authors:  Xiang Kong; Guo-Dong Wang; Ming-Zhe Ma; Ru-Yuan Deng; Li-Qun Guo; Jun-Xiu Zhang; Jie-Ren Yang; Qing Su
Journal:  Nutrients       Date:  2015-06-09       Impact factor: 5.717

4.  Acute exposure to a precursor of advanced glycation end products induces a dual effect on the rat pancreatic islet function.

Authors:  Ghada Elmhiri; Luiz Felipe Barella; Didier Vieau; Sylvaine Camous; Paulo C F Mathias; Latifa Abdennebi-Najar
Journal:  Int J Endocrinol       Date:  2014-11-17       Impact factor: 3.257

5.  Control of Insulin Secretion by Production of Reactive Oxygen Species: Study Performed in Pancreatic Islets from Fed and 48-Hour Fasted Wistar Rats.

Authors:  Ana Cláudia Munhoz; Patrícia Riva; Daniel Simões; Rui Curi; Angelo Rafael Carpinelli
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.